Work

Evaluating disease severity in idiopathic pulmonary fibrosis

Year: 2017
Type: review
Abstract: Accurate assessment of idiopathic pulmonary fibrosis (IPF) disease severity is integral to the care provided to patients with IPF. However, to date, there are no generally accepted or validated staging systems. There is an abundance of data on using information acquired from physiological, radiological and pathological parameters, in isolation or in combination, to assess disease severity in IPF. Recently, there has been interest in using serum biomarkers and computed tomography-derived quantitative lung fibrosis measures to stage disease severity in IPF. This review will focus on the suggested methods for staging IPF, at baseline and on serial assessment, their strengths and limitations, as well as future developments.
Language: English
Field: Medicine
Open Access status: diamond
OpenAlex ID: W2750993488
FWCI: 1.559
Cites: 100
Cited by: 102
Related to: 10
Parts: 1